O46.092 Antepartum hemorrhage with other coagulation defect, second trimester

Name of the Condition

• Antepartum Hemorrhage with Other Coagulation Defect, Second Trimester

Summary

Antepartum hemorrhage refers to bleeding from the genital tract during pregnancy, typically after 20 weeks of gestation. When associated with another coagulation defect, the bleeding may be exacerbated by underlying issues with blood clotting, which can complicate management and increase risks to both the mother and fetus. This code specifies the condition occurs in the second trimester and involves a coagulation defect other than afibrinogenemia.

Causes

The coagulation defect in antepartum hemorrhage may arise from preexisting conditions such as inherited clotting disorders, acquired deficiencies (e.g., vitamin K deficiency), or complications like disseminated intravascular coagulation (DIC). These defects can be triggered by severe bleeding, infection, or other systemic issues that disrupt normal clotting mechanisms. Pregnancy-related complications like placental abruption or previa may also contribute to or worsen the coagulation abnormality.

Risk Factors

• Preexisting clotting disorders (e.g., hemophilia, von Willebrand disease)
• Severe infection or sepsis
• Placental abruption or previa
• Trauma or injury to the abdomen
• Multiple pregnancies
• History of bleeding disorders or previous hemorrhage
• Use of anticoagulant medications

Symptoms

• Vaginal bleeding (ranging from spotting to heavy flow)
• Excessive bruising or prolonged bleeding from minor injuries
• Fatigue or weakness (due to blood loss)
• Signs of coagulation issues, such as petechiae or uncontrolled bleeding
• Abdominal pain or cramping

Diagnosis

Diagnosis involves assessing the bleeding pattern and evaluating coagulation parameters through laboratory tests (e.g., prothrombin time, partial thromboplastin time, fibrinogen levels). Imaging studies may be used to identify obstetric causes of bleeding, such as placental abruption or previa. Clinical evaluation of symptoms and medical history helps confirm the diagnosis and determine the underlying coagulation defect.

Treatment Options

Treatment focuses on stabilizing the mother and addressing the bleeding and coagulation defect. This may include blood transfusions, administration of clotting factors or medications to correct coagulation abnormalities, and management of the underlying obstetric cause (e.g., placental abruption). Close monitoring of both mother and fetus is essential, and delivery may be necessary if the condition is severe or unresponsive to treatment.

Prognosis and Follow-Up

Prognosis depends on the severity of the bleeding, the underlying coagulation defect, and the gestational age. Early intervention and appropriate management can improve outcomes, but complications such as preterm delivery or fetal distress may occur. Follow-up care includes monitoring for recurrent bleeding, assessing coagulation status, and managing any long-term effects of the coagulation defect or pregnancy complications.

Complications

• Severe maternal blood loss leading to shock
• Fetal distress or preterm birth
• Placental abruption or previa progression
• Disseminated intravascular coagulation (DIC)
• Maternal or fetal mortality in severe cases

Lifestyle & Prevention

• Avoid activities that increase risk of abdominal trauma.
• Manage preexisting coagulation disorders with prenatal care.
• Report any bleeding or unusual symptoms promptly to healthcare providers.
• Follow recommended prenatal care to monitor for complications.

When to Seek Professional Help

Seek immediate medical attention for:

• Heavy or persistent vaginal bleeding.
• Signs of shock (e.g., dizziness, rapid heartbeat, low blood pressure).
• Severe abdominal pain or cramping.
• Unusual bruising or prolonged bleeding from minor injuries.

Tips for Medical Coders

Document the specific coagulation defect (other than afibrinogenemia) and confirm the second-trimester gestational timing. Ensure clinical documentation supports the diagnosis and differentiates this from other coagulation-related antepartum hemorrhage codes. Verify that the code aligns with the patient’s clinical presentation and obstetric history.